Literature DB >> 16670340

Involvement of CCL18 in allergic asthma.

Patricia de Nadaï1, Anne-Sophie Charbonnier, Cécile Chenivesse, Stéphanie Sénéchal, Clément Fournier, Jules Gilet, Han Vorng, Ying Chang, Philippe Gosset, Benoît Wallaert, André-Bernard Tonnel, Philippe Lassalle, Anne Tsicopoulos.   

Abstract

Allergic asthma is associated with a pulmonary recruitment of Th type 2 cells, basophils, and eosinophils, mainly linked to chemokine production. CCL18 is a chemokine preferentially expressed in the lung, secreted by APCs, induced by Th2-type cytokines, and only present in humans. Therefore, CCL18 may be involved in allergic asthma. PBMC from asthmatics allergic to house dust mite cultured in the presence of Dermatophagoides pteronyssinus 1 (Der p 1) allergen secreted CCL18, 48 and 72 h after stimulation, whereas those from healthy donors did not. Part of CCL18 was directly derived from Der p 1-stimulated plasmacytoid dendritic cells, whereas the other part was linked to monocyte activation by IL-4 and IL-13 produced by Der p 1-stimulated T cells. In bronchoalveolar lavages from untreated asthmatic allergic patients, CCL18 was highly increased compared with controls. Functionally, CCL18 preferentially attracted in vitro-polarized Th2 cells and basophils, but not eosinophils and Th1 cells, and induced basophil histamine and intracellular calcium release. These data show a new function for CCL18, i.e., the recruitment of Th2 cells and basophils, and suggest that CCL18 may play a predominant role in allergic asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670340     DOI: 10.4049/jimmunol.176.10.6286

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Sarah Peterson; Julie A Poposki; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

2.  The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).

Authors:  Rocio T Martinez-Nunez; Fethi Louafi; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

3.  Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis.

Authors:  Jacquelyn Levin; Sheila Fallon Friedlander; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-12

4.  The clinical and environmental determinants of airway transcriptional profiles in allergic asthma.

Authors:  Ivana V Yang; John Tomfohr; Jaspal Singh; Catherine M Foss; Harvey E Marshall; Loretta G Que; Erin McElvania-Tekippe; Sarita Florence; John S Sundy; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2012-01-12       Impact factor: 21.405

5.  The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum.

Authors:  Ingrid U Schraufstatter; Ming Zhao; Sophia K Khaldoyanidi; Richard G Discipio
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

6.  T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.

Authors:  David W Rosenthal; James A DeVoti; Bettie M Steinberg; Allan L Abramson; Vincent R Bonagura
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

7.  Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis.

Authors:  Antoine W T van Lieshout; Jaap Fransen; Marcel Flendrie; Agnes M M Eijsbouts; Frank H J van den Hoogen; Piet L C M van Riel; Timothy R D J Radstake
Journal:  Ann Rheum Dis       Date:  2007-03-09       Impact factor: 19.103

8.  Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma.

Authors:  M L Gavala; E A B Kelly; S Esnault; S Kukreja; M D Evans; P J Bertics; G L Chupp; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

9.  Complex regulation of pulmonary inflammation and fibrosis by CCL18.

Authors:  Kerill Pochetuhen; Irina G Luzina; Virginia Lockatell; Jung Choi; Nevins W Todd; Sergei P Atamas
Journal:  Am J Pathol       Date:  2007-06-14       Impact factor: 4.307

10.  Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum.

Authors:  Hyo-Bin Kim; Chang-Keun Kim; Koji Iijima; Takao Kobayashi; Hirohito Kita
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.